Publications by authors named "Jason D Burch"

Claim this Profile
S
Structural insight into the cGAS active site explains differences between therapeutically relevant species.
Alexander M Skeldon, Li Wang, Nicolas Sgarioto, Ramsay E Beveridge, Silas Chan, Jason D Burch

Commun Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided Hybridization.
Patrick Cyr, Lee D Fader, Jason D Burch, Kelly A Pike, Daniel V Sietsema

ACS Med Chem Lett· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total Synthesis of Aflastatin A.
David A Evans, Jason J Beiger, Jason D Burch, Peter H Fuller, Frank Glorius

J Am Chem Soc· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could AlphaFold revolutionize chemical therapeutics?
Alexander B Tong, Jason D Burch, Daniel McKay, Carlos Bustamante, Michael A Crackower

Nat Struct Mol Biol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel pyridone EP agonists featuring allylic alcohol ω-chains.
Stéphane Dorich, Jennifer H Cox, Jason D Burch, Félix Chagnon, Bin Chen

Bioorg Med Chem Lett· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminoalkylation of [1.1.1]Propellane Enables Direct Access to High-Value 3-Alkylbicyclo[1.1.1]pentan-1-amines.
Jonathan M E Hughes, David A Scarlata, Austin C-Y Chen, Jason D Burch, James L Gleason

Org Lett· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase.
Nicole Blaquiere, Georgette M Castanedo, Jason D Burch, Leonid M Berezhkovskiy, Hans Brightbill

J Med Chem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment Molecular Orbital Method Applied to Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors.
Alexander Heifetz, Giancarlo Trani, Matteo Aldeghi, Colin H MacKinnon, Paul A McEwan, Jason D Burch

J Med Chem· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory response.
Yonglian Sun, Ivan Peng, Joshua D Webster, Eric Suto, Justin Lesch, Jason D Burch

Sci Signal· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in Vivo.
Jason D Burch, Kathy Barrett, Yuan Chen, Jason DeVoss, Charles Eigenbrot

J Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK).
Giancarlo Trani, John J Barker, Steven M Bromidge, Frederick A Brookfield, Jason D Burch

Bioorg Med Chem Lett· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors.
Jason D Burch, Kevin Lau, John J Barker, Fred Brookfield, Yong Chen

J Med Chem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors.
Richard M Pastor, Jason D Burch, Steven Magnuson, Daniel F Ortwine, Yuan Chen

Bioorg Med Chem Lett· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.
Bernard Côté, Jason D Burch, Ernest Asante-Appiah, Chris Bayly, Leanne Bédard

Bioorg Med Chem Lett· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitors.
Steven T Staben, Jianwen A Feng, Karen Lyle, Marcia Belvin, Jason Boggs, Jason D Burch

J Med Chem· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK).
Colin H MacKinnon, Kevin Lau, Jason D Burch, Yuan Chen, Jonathon Dines

Bioorg Med Chem Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor.
Jason D Burch, Julie Farand, John Colucci, Claudio Sturino, Yves Ducharme

Bioorg Med Chem Lett· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-pot synthesis of benzofurans via palladium-catalyzed enolate arylation with o-bromophenols.
Christian Eidamshaus, Jason D Burch

Org Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutual antagonistic relationship between prostaglandin E(2) and IFN-gamma: Implications for rheumatoid arthritis.
Marie-Claude Mathieu, Simon Lord-Dufour, Virginie Bernier, Yves Boie, Jason D Burch

Eur J Immunol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective total synthesis of callipeltoside A: two approaches to the macrolactone fragment.
David A Evans, Jason D Burch, Essa Hu, Georg Jaeschke

Tetrahedron· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
Jason D Burch, Michel Belley, Réjean Fortin, Denis Deschênes, Mario Girard

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex aldol reactions for the construction of dense polyol stereoarrays: synthesis of the C33-C36 region of aflastatin A.
David A Evans, Frank Glorius, Jason D Burch

Org Lett· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and confirmation of the absolute stereochemistry of the (-)-aflastatin A C9-C27 degradation polyol.
David A Evans, William C Trenkle, Jing Zhang, Jason D Burch

Org Lett· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective total synthesis of callipeltoside A.
David A Evans, Essa Hu, Jason D Burch, Georg Jaeschke

J Am Chem Soc· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis